Georgie...that's what I am saying. I will be dropping the Chair an e-mail. No discount placements unless its an involved business partner. They don't need the cash. We don't want the register strengthened via this route - and importantly its not what he guided at the AGM.
They are amply funded to Remplir FDA approval and US mkt entry. Take out the R&D they are already cash flow positive. Once they have Remplir in US mkts, along with existing Straite sales (and Remplir AU sales) they will very soon likely be cash flow positive on what remaining R&D they have getting ATI and CelGro Tendon to mkt.
JVDW needs a little reminder of his ultimate main stakeholders => shareholders beyond insiders.
Ann: Strategic Placement to Raise $3.5 million, page-33
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.31M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.5¢ | 35.5¢ | $65.26K | 181.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 56760 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 5000 | 1 |
View Market Depth
| Last trade - 15.04pm 28/06/2024 (20 minute delay) ? |
| OCC (ASX) Chart |